A rising number of studies indicate that the climate may have an...
Category:
Health
Latest
What is Omicron’s XBB.1.5 Sub-variant? Should India be worried?
"Immune evasiveness is the ability of the virus to infect people...
Why China’s latest Covid wave has sparked global panic
Beijing: China is experiencing a huge Covid-19 surge after years of...
India is at a disadvantage in dealing with pandemics
Even in the short term, though, there are quick lessons to learn. Consider one success story in India — the outbreak in the massive Mumbai slum of Dharavi, where “Slumdog Millionaire” was famously set. Early on, it seemed that Dharavi would almost certainly suffer an exponential rise in cases. Instead, an innovative combination of privately staffed fever clinics, repurposed public infrastructure and manpower from non-governmental organizations managed to flatten the curve there.
India’s coronavirus cases rise by a daily record of 55,078, death toll at 35,747
Covid-19 infections in the country jumped by 55,078 in the past 24 hours, while the death toll rose by 779 to 35,747, the Ministry of Health and Family Welfare said on its website.Maharashtra has reported its highest single-day spike of 11,147 cases and its tally now stands at 4,11,798. Tamil Nadu’s corona tally has shot up to 239,978 with 5,864 fresh cases. Both states have extended their lockdowns until August 31, with some relaxations.
India’s Covid-19 recovery rate now stands at 64.54 per cent, said Union Health Minister Dr Harsh Vardhan here on Friday.
Suspension of international flights extended till August 31: DGCA
However, this restriction would not applicable for international all-cargo operations and flights specifically approved by the DGCA.
During the suspension period, more than 2,500 repatriation flights by foreign carriers to uplift stranded passengers to/ from India have been approved, the statement said.
“Coronavirus effects will be felt for decades”:WHO
“The pandemic is a once-in-a-century health crisis, the effects of which will be felt for decades to come.”
Large U.S. COVID-19 vaccine trials will exclude pregnant women for now
Bioethicists, vaccine and maternal health experts have argued for years that pregnant women should be included early in trials of pandemic vaccines so they would not need to wait until long after a successful candidate emerges. That debate fell on deaf ears in recent outbreaks of Ebola and Zika, but has taken on new urgency in the era of COVID-19, as studies show pregnant women are at increased risk of severe disease from the new coronavirus.
U.S.consumer spending presses ahead; declining income poses challenge
The extra unemployment checks are worth about $75 billion per month and accounted for nearly 5% of personal income in June. A staggering 30.2 million Americans were receiving unemployment checks in the week ending July 11. Though government welfare payments have been declining after jumping 110% in April, unemployment benefits increased 8.5% in June.
Consumers socked away $1.3 trillion over the last three months. Savings funded spending last month, pulling the saving rate down to a still-high 19% from 24.2% in May.
Southeast Asia poverty to surge in ‘socio-economic crisis’:U.N.
“Without alternative income, formal social protection systems or savings to buffer these shocks, workers and their families will be pushed into poverty, reversing decades of poverty reduction.”
The region-wide economy was expected to contract by 0.4 per cent in 2020, it said, while remittances from Southeast Asians working abroad were likely to fall by 13 per cent or $10 billion.
Gilead raises sales outlook to include COVID-19 treatment remdesivir
Demand for remdesivir continues to outstrip supply in many parts of the world.
Gilead’s chief executive, Daniel O’Day, on a conference call, said the company expects by the end of September to be producing enough remdesivir to meet real-time global demand.
Gilead said it still expects to manufacturer 2 million or more remdesivir treatment courses cumulatively in 2020, and its revenue outlook reflects expected sales of up to 1.5 million courses this year.
Antibody drug lowers risk of death in elderly COVID-19 patients – Cuban study
Researchers,including from Cuba’s Center of Molecular Immunology,which developed itolizumab, said timely use of the drug in combination with standard therapy helped reduce inflammation and prevented COVID-19 from worsening.
Children carry COVID-19 virus, small study finds
Data on children as sources of coronavirus spread are sparse, and early reports did not find strong evidence of children as major contributors to the deadly virus that has killed 669,632 people globally.
Understanding the transmission potential in children will be key to developing public health guidelines, said the researchers who published the study in the journal JAMA Pediatrics.